Search

When Memorial Sloan Kettering Cancer Center (MSK) opened its doors along Commack Road in 2002, eastern Long Islanders no longer needed to navigate congested roadways and train lines bound for Manhattan to receive personalized cancer care. Today, more than 14 years later, MSK is reinforcing its commitment to the local community in the form of a 38,000-plus-square-foot addition complete with enhancements to both clinical programs and physical spaces.

… Monday, October 17, 2016 When Memorial Sloan Kettering opened its doors along Commack Road in 2002, eastern Long Islanders no longer needed to navigate congested roadways and train lines bound for Manhattan to receive personalized cancer care. Today, more than 14 years later, MSK is reinforcing its commitment

Memorial Sloan Kettering announced the appointment of Pereira & O’Dell in New York as its creative agency of record and Media Storm as its media agency of record.

… Tuesday, February 25, 2014 Memorial Sloan Kettering announced the appointment of Pereira & O’Dell in New York as its creative agency of record and Media Storm as its media agency of record following competitive reviews that concluded earlier this month. “For 130 years, Memorial Sloan Kettering has focused

MSK physicians and scientists are involved in notable research to be presented during the virtual meeting.

… Friday, October 23, 2020 Thousands of oncology experts from around the world will tune in October 25 to 28 for the American Society for Radiation Oncology’s (ASTRO) Annual Meeting. During the virtual meeting, new results from clinical trials and other research studies will be presented in conjunction

Mutations in a gene called FOXA1 are responsible for a distinct class of prostate cancer tumors, MSK researchers have found.

… Wednesday, June 26, 2019 Summary Researchers at Memorial Sloan Kettering have identified molecular changes in a protein that promote a distinct type of prostate cancer. The findings suggest that this protein could be a good drug target for men with this form of the disease. Prostate cancer is not one

Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.

… Monday, September 12, 2022 Promising new drugs have begun to transform the treatment of bladder (or urothelial) cancer, the sixth most common form of the disease in the U.S., and the fourth most common in men. In particular, two drug classes, antibody-drug conjugates (ADCs) and checkpoint inhibitors,

Learn the most frequently asked questions about immunotherapy, a form of cancer treatment that uses the body's own immune system to overpower cancer cells. Learn who it can help, how it works, and how experts at MSK are finding ways to make it benefit more people, including new combinations with other cancer treatments like chemotherapy, surgery, radiation and more.

… Tuesday, November 7, 2023 Immunotherapy is one of the most promising approaches to cancer treatment . Unlike other forms of cancer treatment, in which drugs or radiation target cancer cells directly, immunotherapy targets your immune system, boosting its innate power to fight the cancer. But how does

After receiving a stem cell transplant for multiple myeloma, John Savarese developed graft-versus-host disease (GVHD). MSK’s specialized GVHD clinic got him back to feeling like himself again.

… Thursday, April 7, 2022 When John Savarese went to see Memorial Sloan Kettering Cancer Center (MSK) hematologic oncologist Doris Ponce for the first time in the fall of 2021, he was not well. “I felt like I was 100 years old,” says the 63-year-old retired air traffic controller and Brooklyn native. “

MSK experts acted quickly to understand the possible effects of COVID-19 on cancer patients and drew on vast experience to explore new treatments.

… Thursday, October 1, 2020 In March 2020, medical oncologist Santosha Vardhana was faced with a new challenge: Many of his patients with lymphoma were becoming infected with the COVID-19 virus. As he saw more cases, Dr. Vardhana noticed a troubling pattern begin to emerge. Patients were managing well

Lab mice who had lactose removed from their diets had a decreased risk of infection with the Enterococcus bacterium.

… Friday, November 29, 2019 Summary An international team led by scientists from MSK has shown for the first time that foods containing lactose, a sugar that’s naturally found in milk and dairy products, help Enterococcus thrive in the gut, at least in mice. Infections with the Enterococcus bacterium are

Learn how 4-year-old Sienna, her family, and the people of MSK Kids inspire each other to continue improving treatments for all children with cancer.

… Thursday, September 4, 2025 When 4-year-old Sienna skips into MSK Kids wearing rainbows and a big smile, the whole space lights up.   “Despite facing this very serious disease and going through difficult treatment, Sienna is always so happy and upbeat,” says her doctor, pediatric hematologist-oncologist